Clinic
Saint Barnabas Outpatient Centers
Saint Barnabas Outpatient Centers was paid $5.83M by Medicaid between Jan 2018 and Nov 2024, across 53 billing codes. Its largest line is 70553, Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences — 27% of everything it billed.
33Billing provider infoSAINT BARNABAS OUTPATIENT CENTERS
LIVINGSTON, NJ 07039
LIVINGSTON, NJ 07039
33aNPI1790747491assigned 04/06/2006
33bProvider typeMagnetic Resonance Imaging (MRI) Clinic/Center
28Total paid$5.83M
24GClaims43,656
24DCodes billed53
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Magnetic Resonance Imaging (MRI) Clinic/Center providers in New Jersey
Rank by total paid#1 of 13
Median peer was paid$23K
This provider vs. median256×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,124 | $636K | |
| 2019 | 4,355 | $569K | |
| 2020 | 4,324 | $563K | |
| 2021 | 6,985 | $928K | |
| 2022 | 7,436 | $1.05M | |
| 2023 | 8,038 | $1.11M | |
| 2024incomplete | 8,394 | $974K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 27% | 1,933 | 1,867 | $1.55M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 8.8% | 1,172 | 1,107 | $516K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 8.7% | 6,212 | 6,046 | $505K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 8.2% | 457 | 389 | $477K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 4.3% | 1,851 | 1,816 | $250K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.3% | 827 | 783 | $249K |
| 76641 | 3.7% | 2,048 | 1,963 | $218K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 3.7% | 1,891 | 1,832 | $214K |
| 76830 | Ultrasound, transvaginal | 3.0% | 1,488 | 1,448 | $178K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 2.4% | 269 | 256 | $142K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 2.3% | 322 | 304 | $135K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2.3% | 4,774 | 4,611 | $134K |
41 more codes
| 77049 | 2.2% | 383 | $126K | |
| 77080 | 1.8% | 1,462 | $103K | |
| 76642 | 1.7% | 1,708 | $97K | |
| 77065 | Tomosynthesis, mammo | 1.3% | 1,083 | $78K |
| 77066 | Tomosynthesis, mammo | 1.3% | 708 | $76K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1.3% | 436 | $76K |
| 71250 | 1.0% | 413 | $59K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,915 | $57K |
| 72197 | <1% | 80 | $55K | |
| 72110 | <1% | 766 | $50K | |
| 76770 | <1% | 417 | $49K | |
| 74183 | <1% | 73 | $48K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 1,446 | $48K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 931 | $46K |
| 76536 | <1% | 398 | $40K | |
| 73564 | <1% | 896 | $39K | |
| 72141 | <1% | 118 | $37K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 3,172 | $34K |
| 74241 | <1% | 247 | $26K | |
| 73030 | <1% | 600 | $24K | |
| 73502 | <1% | 297 | $16K | |
| 77059 | <1% | 13 | $14K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 319 | $11K |
| 73562 | <1% | 258 | $8K | |
| OP250 | <1% | 274 | $7K | |
| 74240 | <1% | 61 | $7K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 479 | $5K |
| 77072 | <1% | 143 | $5K | |
| 73560 | <1% | 202 | $4K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 702 | $3K |
| 73610 | <1% | 53 | $3K | |
| 77081 | <1% | 120 | $2K | |
| 76775 | <1% | 26 | $2K | |
| 73630 | <1% | 56 | $2K | |
| A4648 | Tissue marker, implantable, any type, each | <1% | 22 | $1K |
| 73130 | <1% | 19 | $1K | |
| 76377 | <1% | 32 | $980.33 | |
| OP272 | <1% | 20 | $597.14 | |
| 73110 | <1% | 15 | $269.69 | |
| 0159T | <1% | 12 | $230.67 | |
| J3490 | Unclassified drugs | <1% | 37 | $11.62 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALBAN, GREGORY (ASSISTANT VICE PRESIDENT OF FINANCE)
Parent organizationSAINT BARNABAS OUTPATIENT CENTERS